Hepatic Cell News Volume 4.29 | Aug 7 2020

    0
    18







    2020-08-07 | HCN 4.29


    Hepatic Cell News by STEMCELL Technologies
    Vol. 4.29 – 7 August, 2020
    TOP STORY

    HNF4α Regulates Sulfur Amino Acid Metabolism and Confers Sensitivity to Methionine Restriction in Liver Cancer

    The authors report that hepatocyte nuclear factor 4α (HNF4α) dictated the sensitivity of liver cancer to methionine restriction. They showed that hepatic sulfur amino acid metabolism was under transcriptional control of HNF4α.
    [Nature Communications]

    Full Article

    Pathogen infection studies lacked an optimal culture system. Then she used organoids.
    PUBLICATIONSRanked by the impact factor of the journal

    Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma

    To identify hepatocellular carcinoma (HCC) signaling networks that determine responses to kinase inhibitors (KIs), scientists applied a pharmacoproteomics approach integrating kinome activity in 17 HCC cell lines with their responses to 299 KIs, resulting in a comprehensive dataset of pathway-based drug response signatures.
    [Cell Systems]

    AbstractPress ReleaseGraphical Abstract

    MicroRNA-148a-3p Inhibits Progression of Hepatocelluar Carcimoma by Repressing SMAD2 Expression in an Ago2 Dependent Manner

    Investigators found that SMAD2 was highly expressed in hepatocellular carcinoma (HCC) and elevated SMAD2 expression predicted shorter overall survival time for HCC patients. SMAD2 promoted mobility and proliferation of HCC cells in vitro.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Tonicity-Responsive Enhancer-Binding Protein Promotes Stemness of Liver Cancer and Cisplatin Resistance

    Tonicity-responsive enhancer binding protein (TonEBP) was required for the tumorigenesis and self-renewal of liver cancer stem cells. Cisplatin induced the recruitment of the ERCC1/XPF dimer to the chromatin in a TonEBP-dependent manner leading to DNA repair and cisplatin resistance.
    [Ebiomedicine]

    Full Article

    The AKT-Independent MET–V-ATPase–Mtor Axis Suppresses Liver Cancer Vaccination

    Scientists investigated the regulatory effect and potential mechanism of hepatocyte growth factor receptor (MET, also known as HGFR) on tumor vaccinations for liver cancer in mice.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Intestinal TLR9 Deficiency Exacerbates Hepatic IR Injury via Altered Intestinal Inflammation and Short‐Chain Fatty Acid Synthesis

    Mechanistically, butyrate induced small intestinal IL‐10 expression and downregulated claudin‐2 expression. IL‐10 neutralization abolished the protective effects of butyrate against hepatic IR injury.
    [FASEB Journal]

    Full Article

    Berberine Improves Intralipid-Induced Insulin Resistance in Murine

    Investigators showed that berberine administration markedly ameliorated intralipid-induced insulin resistance without affecting blood glucose. They used human skeletal muscle cells, hepatocytes, human umbilical vein endothelial cells, and CypD knockout mice to investigate metabolic and molecular alternations.
    [Acta Pharmacologica Sinica]

    Abstract

    Selenoprotein P Inhibits Cell Proliferation and ROX Production in HCC Cells

    Researchers observed the expression of selenoprotein P in livers from patients with hepatocellular carcinoma (HCC) and explored its effect on HCC cells.
    [PLoS One]

    Full Article

    Watch 'collaborating to accelerate COVID-19 research'
    REVIEWS

    The Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury

    Scientists provide an update on the progress regarding the interactions between secretin and the biliary epithelia in normal and pathological conditions, underlining the aspects that suggests modulation of secretin pathway as a possible therapeutic approach for chronic cholestatic human liver disease.
    [Hepatology]

    Abstract

    Immunological Distinctions between Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma

    The authors differentiate the roles of specific immune cell subsets in nonalcoholic steatohepatitis and hepatocellular carcinoma pathogenesis.
    [Experimental and Molecular Medicine]

    Full Article

    INDUSTRY AND POLICY NEWS

    Everest Medicines Announces First Patient Dosed in a Phase Ib/II Study of FGF401 in Combination with Pembrolizumab for the Treatment of Advanced Solid Tumors

    Everest Medicines has announced that the first patient has been dosed in a Phase Ib/II study evaluating FGF401 in combination with PD-1 inhibitor, pembrolizumab, in patients with advanced solid tumors, such as hepatocellular carcinoma.
    [Everest Medicines]

    Press Release

    Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis (NASH)

    Alnylam Pharmaceuticals, Inc. has submitted a clinical trial authorization (CTA) application to The Medicines and Healthcare Products Regulatory Agency in the UK to initiate a Phase I study of ALN-HSD, an investigational RNAi therapeutic targeting HSD17B13 for the treatment of NASH.
    [Alnylam Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    The Digital International Liver Congress™ 2020

    August 27 – 29
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Research Postdoctoral Fellow – Hyperglycemia, NAFLD & T2D

    Johns Hopkins School of Medicine – Baltimore, Maryland, United States

    Postdoctoral Positions – Inflammatory Bowel Diseases and Tumor Immunology

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    Postdoctoral Fellow – Diabetes and Cancer Metabolism

    City of Hope – Duarte, California, United States

    Postdoctoral Fellow – Pancreatic and Liver Malignancies

    Weill Cornell Medicine – New York, New York, United States

    Post Doctoral Scholarship – Molecular Metabolism

    University of Gothenburg – Gothenburg, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter